Therapy of migraine

被引:0
作者
Obermann, Mark [1 ]
Diener, Hans Christoph [1 ]
机构
[1] Univ Klinikum Essen, Neurol Klin & Poliklin, D-45122 Essen, Germany
来源
PSYCHOPHARMAKOTHERAPIE | 2008年 / 15卷 / 02期
关键词
migraine; acute therapy; prophylaxis;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Migraine is one of the most common forms of primary headache with a lifetime prevalence for women of over 25 %. Migraine is characterized by episodes of severe, commonly unilateral, pulsating headache and is mostly accompanied by nausea, vomiting, photophobia, phono- and osmophobia. First line therapy for the acute migraine attack are analgesics like paracetamol and acetylsalicylic acid or specific drugs like triptans. To prevent the development of medication over-use headache prophylactic treatment should be considered for patients with more than three migraine attacks per month or high risk for the development of chronic daily headache. First line substances for migraine prophylaxis are betablockers, flunarizine and topiramate. Additional behavioural measures should be recommended as support for medical treatment such as aerobic exercise, relaxation techniques, and stress management.
引用
收藏
页码:81 / 87
页数:7
相关论文
共 86 条
[61]   No effect of eletriptan administration during the aura phase of migraine [J].
Olesen, J ;
Diener, HC ;
Schoenen, J ;
Hettiarachchi, J .
EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 (10) :671-677
[62]   Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study [J].
Ondo, WG ;
Vuong, KD ;
Derman, HS .
CEPHALALGIA, 2004, 24 (01) :60-65
[63]   The efficacy and safety of venlafaxine in the prophylaxis of migraine [J].
Ozyalcin, SN ;
Talu, GK ;
Kiziltan, E ;
Yucel, B ;
Ertas, M ;
Disci, R .
HEADACHE, 2005, 45 (02) :144-152
[64]   Prophylaxis of migraine with oral magnesium: Results from a prospective, multi-center, placebo-controlled and double-blind randomized study [J].
Peikert, A ;
Wilimzig, C ;
KohneVolland, R .
CEPHALALGIA, 1996, 16 (04) :257-263
[65]   The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -: a double-blind, multicentre, randomized placebo-controlled dose-response study [J].
Pfaffenrath, V ;
Diener, HC ;
Fischer, M ;
Friede, M ;
Henneicke-von Zepelin, HH .
CEPHALALGIA, 2002, 22 (07) :523-532
[66]   Magnesium in the prophylaxis of migraine - A double-blind, placebo-controlled study [J].
Pfaffenrath, V ;
Wessely, P ;
Meyer, C ;
Isler, HR ;
Evers, S ;
Grotemeyer, KH ;
Taneri, Z ;
Soyka, D ;
Gobel, H ;
Fischer, M .
CEPHALALGIA, 1996, 16 (06) :436-440
[67]   EPIDEMIOLOGY OF HEADACHE IN A GENERAL-POPULATION - A PREVALENCE STUDY [J].
RASMUSSEN, BK ;
JENSEN, R ;
SCHROLL, M ;
OLESEN, J .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1991, 44 (11) :1147-1157
[68]   ASPIRIN PHARMACOKINETICS IN MIGRAINE - THE EFFECT OF METOCLOPRAMIDE [J].
ROSSLEE, LM ;
EADIE, MJ ;
HEAZLEWOOD, V ;
BOCHNER, F ;
TYRER, JH .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (06) :777-785
[69]   Course of migraine during pregnancy and postpartum: a prospective study [J].
Sances, G ;
Granella, F ;
Nappi, RE ;
Fignon, A ;
Ghiotto, N ;
Polatti, F ;
Nappi, G .
CEPHALALGIA, 2003, 23 (03) :197-205
[70]   Prevalence of frequent headache in a population sample [J].
Scher, AI ;
Stewart, WF ;
Liberman, J ;
Lipton, RB .
HEADACHE, 1998, 38 (07) :497-506